Specialty
Documentation for prior authorizations to ensure clinically appropriate utilization of autoimmune therapies More
Briefing
Vice President, Product Development, CVS Health
During his 16 years with the organization, Fredell has focused on the ideation, commercialization and ongoing management of clinical products and services ranging from those designed to manage unnecessary pharmacy spend improving overall healthcare through adherence and closing gaps in care. Currently, he and his team are focused on evolving formulary and cost management strategies within both the pharmacy and medical benefits including designs for utilization management, preferred drug strategies, value-based contracting, and plan design programs. Prior to CVS Health, Fredell was part of the pharmacy department of UPMC Health Plan and earned his PharmD from the University of Pittsburgh.
Specialty
Enhanced Specialty Guideline Management Offers Payors Choice and Flexibility in Coverage for Acthar Gel More
Briefing
Cost Management
2022 CVS Caremark Formulary Updates Deliver Exceptional Value and Cost Management More
Briefing
Cost Management
Assessing New-to-Market Biologics and Biosimilars
CVS Health offers strategies for addressing new-to-market products to ensure access to clinically appropriate insulin or other medications. More
Commentary
Cost Management
Payor strategies for specialty drug spend must strike a balance between affordability and member experience. More
Commentary
Specialty
Innovative strategies can help payors manage pharmacy costs and care for plan members with psoriasis. More
Briefing
Cost Management
Changes to CVS Caremark template formularies effective January 1, 2021 continue our legacy of innovation as well as delivering value and quality care — helping clients save money... More
Briefing